not tagged
not tagged
important data from the hovon group at #17icml on a randomized study in high-risk bl. comparable efficacy with da-epoch-r compared to r-codox-m/r-ivac, but more infections (including serious), transfusions, and hospitalizations with r-codox-m/r-ivac 
Clinician and researcher specializing in lymphoma. Tweets are my own.